Underdosing of oth fibrinolysis-affecting drugs, subs encntr

This code indicates that a patient has received an insufficient amount of a medication intended to dissolve blood clots (fibrinolysis-affecting drug), and this underdosing is being addressed during a follow-up visit. This can lead to inadequate therapeutic effect and potential complications from the underlying condition requiring the fibrinolytic agent.

Use this code when documenting a patient's subsequent visit where the underdosing of a fibrinolysis-affecting drug is being managed, monitored, or further investigated. This applies to situations where the initial treatment or prescription was insufficient, or the patient did not adhere to the prescribed dosage, and they are now presenting for ongoing care related to this issue.

• Always assign an additional code for the specific adverse effect or complication resulting from the underdosing, if applicable.
• Ensure documentation clearly specifies the drug involved and that the encounter is for follow-up care related to the underdosing.
• Distinguish from initial encounters (use 'A' for initial) or sequela (use 'S' for sequela) when selecting the appropriate seventh character.